875288-80-5 Usage
Fatty Acid Structure
The compound is a derivative of docosahexaenoic acid, which is a long-chain polyunsaturated fatty acid with 22 carbon atoms and six double bonds.
Molecular Configuration
The double bonds in the compound are in the cis configuration, with the specific configuration being 2E, 7Z, 10Z, 13Z, 16Z, 19Z.
Omega-3 Fatty Acid
Docosahexaenoic acid is a type of omega-3 fatty acid, which is an essential nutrient that the body cannot produce on its own and must be obtained through diet or supplementation.
Fish Oil Source
The compound is found most abundantly in fish oil, which is a natural source of omega-3 fatty acids.
Dietary Supplement
The methyl ester form of docosahexaenoic acid is commonly used as a dietary supplement, particularly in infant formulas and nutritional products.
Health Benefits
Docosahexaenoic acid is known for its numerous health benefits, including supporting brain health, reducing inflammation, and improving heart health.
Stability
The methyl ester form is more stable than the parent compound, making it easier to use in various applications and less prone to oxidation.
Food Fortification
The compound is often used to fortify food products, such as cereals and dairy products, with omega-3 fatty acids.
Check Digit Verification of cas no
The CAS Registry Mumber 875288-80-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,2,8 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 875288-80:
(8*8)+(7*7)+(6*5)+(5*2)+(4*8)+(3*8)+(2*8)+(1*0)=225
225 % 10 = 5
So 875288-80-5 is a valid CAS Registry Number.
875288-80-5Relevant articles and documents
COMPOUND, COMPOSITION AND USES THEREOF
-
, (2017/05/10)
The compositions and compounds of formula I, formula II, formula III which includes a salt of polyunsaturated fatty acids in a molecular conjugate with amino acid isoleucine or its polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection administration. Such compositions may be used to treatment of hyperglycemia, metabolic syndrome, diabetes, pre-diabetes, lowering triglycerides or its associated complications.
